These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33318004)

  • 1. The Pharmacodynamic-Toxicodynamic Relationship of AUC and
    Avedissian SN; Pais G; Liu J; O'Donnell JN; Lodise TP; Neely M; Prozialeck WC; Lamar PC; Becher L; Scheetz MH
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model.
    Avedissian SN; Pais GM; O'Donnell JN; Lodise TP; Liu J; Prozialeck WC; Joshi MD; Lamar PC; Becher L; Gulati A; Hope W; Scheetz MH
    J Antimicrob Chemother; 2019 Aug; 74(8):2326-2334. PubMed ID: 31065686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury.
    O'Donnell JN; Rhodes NJ; Lodise TP; Prozialeck WC; Miglis CM; Joshi MD; Venkatesan N; Pais G; Cluff C; Lamar PC; Briyal S; Day JZ; Gulati A; Scheetz MH
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.
    Rhodes NJ; Prozialeck WC; Lodise TP; Venkatesan N; O'Donnell JN; Pais G; Cluff C; Lamar PC; Neely MN; Gulati A; Scheetz MH
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5742-51. PubMed ID: 27431226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors: correlations with clinical characteristics and safety.
    Guo F; Letrent SP; Munster PN; Britten CD; Gelmon K; Tolcher AW; Sharma A
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):97-109. PubMed ID: 17805538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Performance of Urinary Biomarkers for Vancomycin-Induced Kidney Injury According to Timeline of Injury.
    Pais GM; Avedissian SN; O'Donnell JN; Rhodes NJ; Lodise TP; Prozialeck WC; Lamar PC; Cluff C; Gulati A; Fitzgerald JC; Downes KJ; Zuppa AF; Scheetz MH
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 30988153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin Pharmacokinetics in a Pregnancy Rat Model.
    Avedissian SN; Pais GM; Pham M; Liu J; Chang J; Hlukhenka K; Prozialeck W; Griffin B; Gulati A; Joshi MD; Mu Y; Scheetz MH
    Antimicrob Agents Chemother; 2022 May; 66(5):e0005622. PubMed ID: 35446134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid and Plasma Concentrations of Cefepime.
    Avedissian SN; Pais G; Joshi MD; Rhodes NJ; Scheetz MH
    mSphere; 2019 Jan; 4(1):. PubMed ID: 30700511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin-Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention.
    Pais GM; Liu J; Zepcan S; Avedissian SN; Rhodes NJ; Downes KJ; Moorthy GS; Scheetz MH
    Pharmacotherapy; 2020 May; 40(5):438-454. PubMed ID: 32239518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of an AUC
    Chavada R; Ghosh N; Sandaradura I; Maley M; Van Hal SJ
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular Function and Urinary Biomarker Changes between Vancomycin and Vancomycin plus Piperacillin-Tazobactam in a Translational Rat Model.
    Chang J; Pais GM; Valdez K; Marianski S; Barreto EF; Scheetz MH
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0213221. PubMed ID: 35007142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus pharmacokinetics of once- versus twice-daily formulations in de novo kidney transplantation: a substudy of a randomized phase III trial.
    Wlodarczyk Z; Ostrowski M; Mourad M; Krämer BK; Abramowicz D; Oppenheimer F; Miller D; Dickinson J; Undre N
    Ther Drug Monit; 2012 Apr; 34(2):143-7. PubMed ID: 22406656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin-Resistant Staphylococcus aureus.
    Stockmann C; Olson J; Rashid J; Lubsch L; Young DC; Hersh AL; Frymoyer A; Ampofo K; Liu X; Wang Y; Sherwin CMT; Zobell JT
    J Clin Pharmacol; 2019 Feb; 59(2):198-205. PubMed ID: 30371946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Pharmacodynamics of Twice Daily and Once Daily Regimens of Empagliflozin in Healthy Subjects.
    Macha S; Brand T; Meinicke T; Link J; Broedl UC
    Clin Ther; 2015 Aug; 37(8):1789-96. PubMed ID: 26138865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Metabolomics From a Dose-Fractionated Polymyxin B Rat Model of Acute Kidney Injury.
    Locci E; Liu J; Pais GM; Chighine A; Kahnamoei DA; Xanthos T; Chalkias A; Lee A; Hauser AR; Chang J; Rhodes NJ; d'Aloja E; Scheetz MH
    Int J Antimicrob Agents; 2022 Jul; 60(1):106593. PubMed ID: 35460851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the accuracy of two Bayesian forecasting programs in estimating vancomycin drug exposure.
    Shingde RV; Reuter SE; Graham GG; Carland JE; Williams KM; Day RO; Stocker SL
    J Antimicrob Chemother; 2020 Nov; 75(11):3293-3302. PubMed ID: 32790842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry.
    Liu MY; Meng SN; Wu HZ; Wang S; Wei MJ
    Clin Ther; 2008 Apr; 30(4):641-53. PubMed ID: 18498913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Vancomycin Loading Doses and Dose Escalation on Glomerular Function and Kidney Injury Biomarkers in a Translational Rat Model.
    Chang J; Pais GM; Engel PL; Klimek P; Marianski S; Valdez K; Scheetz MH
    Antimicrob Agents Chemother; 2023 Feb; 67(2):e0127622. PubMed ID: 36648224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Fetal and Maternal Vancomycin-Induced Kidney Injury during Pregnancy in a Rat Model.
    Joshi MD; Pais GM; Chang J; Hlukhenka K; Avedissian SN; Gulati A; Prozialeck WC; Lamar PC; Zhang Z; Scheetz MH; Griffin B
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.